Divi's Laboratories Ltd.

NSE: DIVISLAB | BSE: 532488 | ISIN: INE361B01024 | Industry: Pharmaceuticals
| Expensive Performer
6223.5000 72.00 (1.17%)
NSE Aug 25, 2025 11:21 AM
Volume: 229.9K
 

6223.50
1.17%
Karvy
Revenues and margins outperform: Divis Labs Net revenues increased by 44.4% YoY to Rs 12.9 bn, which ishigher than our estimates of Rs 10.2 bn for the quarter. The Operatingmargins were at 40% in Q2FY19 (much higher than our estimate of 34.7%) asagainst 31% in Q2FY18 on account of better gross margin and lowerexpenditure.
Divi's Laboratories Ltd. is trading below its 30 day SMA of 6416.8
More from Divi's Laboratori…
All earning calls
Investor presentations from Divi's Laboratori…
All investor presentations